Barnwell Bio

Barnwell Bio, based in the US, specializes in innovative biosurveillance systems that enhance animal health management for producers and veterinarians through actionable data and real-time insights. Founded in 2024, Barnwell Bio is headquartered in New York, US, focusing on biosurveillance technology that supports livestock health management. The company successfully raised USD 6. 000 mn in SEED funding on January 26, 2026, led by Twelve Below.

Other investors in this round included Max Ventures, Dorm Room Fund, Banter Capital, Planeteer Capital, Daybreak, Alumni Ventures Group, AgLaunch, and Ag Ventures Alliance. The firm has completed one deal to date. The founder's background is currently not available. Barnwell Bio specializes in advanced biosurveillance technology designed to enhance animal health management for producers and veterinarians.

Their primary offering is an ongoing biosurveillance platform that equips users with actionable data to anticipate health issues, identify pathogen trends, and implement targeted treatments. This technology allows clients to effectively manage livestock health by making informed decisions regarding interventions, such as evaluating feed additives, vaccines, and biosecurity protocols through real-time data analysis. The firm serves a diverse customer base, including livestock producers and veterinary professionals across various geographical markets, primarily in North America, but also extending to international clients in regions where animal farming and health monitoring are critical. Barnwell Bio generates revenue through a subscription-based model, where clients pay for access to their biosurveillance platform and its associated services.

This structure enables ongoing revenue generation from producers and veterinarians who utilize the platform for continuous health monitoring and intervention management. Partnerships with agricultural entities and veterinary clinics further bolster their revenue stream, allowing for collaborations that enhance product offerings and client reach. Although specific pricing plans are not disclosed, the company's flagship services encompass tiered access levels to their platform, reflecting the varying needs of small to large-scale producers looking to optimize animal health and production efficiency. In January 2026, Barnwell Bio will utilize the USD 6.

000 mn raised in Seed funding to expand its livestock and poultry health monitoring capabilities and develop enhanced data analysis functionalities. The company plans to introduce new products aimed at improving biosurveillance technology in the upcoming year. Additionally, Barnwell Bio is targeting expansion into international markets, with a focus on regions that require robust animal health monitoring solutions.